Introduction: Science as a Networked, Investable Commons The architecture of scientific discovery is undergoing a structural realignment as profound as the transition from analog to digital. For more than half a century, biomedical innovation has depended on a linear pipeline—grant-funded discovery, venture-backed translation, and late-stage commercialization controlled by a narrow set of institutions. That model,…

